Skip to main content

New trial shows nasal spray reduces infection of covid-causing virus by 62%

A new clinical trial led by Queen Mary University of London and Barts Health researchers has shown that the pHOXWELL nasal spray can reduce infection with SARS-CoV-2 - the virus that causes Covid-19 - by 62%. The research was published in the Journal of Clinical Virology.

Published on:
Back to top